Table 2 Classic lipid profile at D1 and D30 by groups of lipid-lowering therapies
Parameters | Simvastatin plus ezetimibe N = 50 | Rosuvastatin monotherapy N = 51 | P value |
|---|---|---|---|
At baseline (D1) | |||
Cholesterol, mg/dL | 188 (174–223) | 199 (168–227) | 0.83 |
LDL-C, mg/dL | 127 (113–153) | 129 (107–150) | 0.73 |
HDL-C, mg/dL | 40 (31–46) | 36 (31–45) | 0.32 |
Triglycerides, mg/dL | 140 (98–214) | 157 (98–232) | 0.42 |
Non-HDL-C, mg/dL | 154 (137–193) | 160 (139–193) | 0.92 |
After 30 days (D30) | |||
Cholesterol, mg/dL | 121 (98–141) | 119 (105–141) | 0.53 |
LDL-C, mg/dL | 58 (43–82) | 61 (50–82) | 0.39 |
HDL-C, mg/dL | 37 (31–44) | 37 (32–40) | 0.93 |
Triglycerides, mg/dL | 133 (107–187) | 140 (100–178) | 0.93 |
Non-HDL-C, mg/dL | 78 (65–112) | 83 (70–105) | 0.66 |